NEW YORK, April 30 — US drugmaker Pfizer Inc reported a nine per cent rise in quarterly profit today, helped by sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar.
The company said net income rose to US$3.88 billion (RM16.03 billion), or 68 cents per share, in the first quarter, from US$3.56 billion, or 59 cents per share, a year earlier.
Revenue rose to US$13.12 billion from US$12.91 billion last year. — Reuters
